Antibiotic Resistance Rising in India, ICMR Warns

Hyderabad: Commonly used antibiotics are becoming less effective against several bacterial infections in India, raising concerns about the ability of hospitals to treat conditions ranging from urinary tract infections to pneumonia and bloodstream infections.
The Indian Council of Medical Research (ICMR), in its Annual Antimicrobial Resistance Surveillance and Research Network Report 2025, has highlighted declining effectiveness of several important antibiotics against major bacterial pathogens.
The report, released on Wednesday, analyzed 1,13,008 culture-positive bacterial isolates collected from 30 tertiary-care hospitals and 20,529 isolates from 34 secondary-care hospitals across India.
The findings indicate growing resistance among bacteria such as Escherichia coli (E. coli) and Klebsiella pneumoniae, both of which are associated with serious infections.
Among E. coli isolates from tertiary-care hospitals, susceptibility to cefotaxime was only 18.4 percent and to ceftazidime 24.7 percent. Susceptibility to piperacillin-tazobactam stood at 42.6 percent, while carbapenem susceptibility ranged between 60 and 65 percent.
The report also identified declining effectiveness of carbapenems, a class of antibiotics considered important for treating serious bacterial infections, particularly when other medicines are ineffective.
Between 2017 and 2025, imipenem susceptibility in Klebsiella pneumoniae declined from 58.5 percent to 36.5 percent. In E. coli, it fell from approximately 80 percent to 66.3 percent.
The surveillance covered infections including typhoid, diarrheal diseases, pneumonia, urinary tract infections, neonatal sepsis and bloodstream infections.
However, the report also identified some encouraging findings. In typhoid infections, Salmonella Typhi continued to show high susceptibility to azithromycin at 99.4 percent, ceftriaxone at 96.6 percent and ampicillin at 93.6 percent.
Nevertheless, susceptibility to ciprofloxacin was only 2 percent, indicating widespread resistance to this antibiotic among the tested isolates.
Dr S. Sukanya of the Nizam's Institute of Medical Sciences (NIMS), Hyderabad, emphasized the importance of culture-based treatment decisions.
She said doctors sometimes prescribe empirical antibiotics based on symptoms and clinical conditions, particularly in critically ill patients when waiting for laboratory results could delay treatment.
Wherever possible, samples should be collected for culture testing before antibiotics are administered. Once laboratory results become available, treatment can be modified according to the patient's condition and the organism's susceptibility.
The report calls for stronger antibiotic stewardship, infection prevention and control measures, and more effective surveillance to discourage indiscriminate antibiotic use.
The findings underline a growing public health challenge: as bacteria develop resistance to existing medicines, infections that were once relatively straightforward to treat can become more difficult and expensive to manage.



Comments